These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 30407089)

  • 21. Hospital drug and therapeutics committees in Australia: is there a role for economic evaluation at the institutional level?
    Gallego G
    Int J Clin Pharm; 2011 Dec; 33(6):895-7. PubMed ID: 21922271
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ASHP national survey of pharmacy practice in hospital settings: Monitoring and patient education--2009.
    Pedersen CA; Schneider PJ; Scheckelhoff DJ
    Am J Health Syst Pharm; 2010 Apr; 67(7):542-58. PubMed ID: 20237382
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Drug and therapeutics committees in Nigeria: evaluation of scope and functionality.
    Fadare JO; Ogunleye O; Obiako R; Orubu S; Enwere O; Ajemigbitse AA; Meyer JC; Enato E; Massele A; Godman B; Gustafsson LL
    Expert Rev Clin Pharmacol; 2018 Dec; 11(12):1255-1262. PubMed ID: 30451035
    [No Abstract]   [Full Text] [Related]  

  • 24. Barriers to implementing pharmacoeconomics: interview study.
    Alefan Q; Hamdouni E; Alhamad H; Mukattash T; Rascati K
    Expert Rev Pharmacoecon Outcomes Res; 2021 Feb; 21(1):93-104. PubMed ID: 32394752
    [No Abstract]   [Full Text] [Related]  

  • 25. Profile and career preferences of pharmacy students at the University of Limpopo, Turfloop Campus, South Africa.
    Modipa SI; Dambisya YM
    Educ Health (Abingdon); 2008 Dec; 21(3):164. PubMed ID: 19967636
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structure and procedures of the pharmacy and therapeutic committees in Spanish hospitals.
    Puigventós F; Santos-Ramos B; Ortega A; Durán-García E
    Pharm World Sci; 2010 Dec; 32(6):767-75. PubMed ID: 20820918
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ASHP national survey of pharmacy practice in hospital settings: Monitoring and patient education-2018.
    Pedersen CA; Schneider PJ; Ganio MC; Scheckelhoff DJ
    Am J Health Syst Pharm; 2019 Jul; 76(14):1038-1058. PubMed ID: 31361881
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Formulary systems and pharmacy and therapeutics committees in the Western Pacific Region: exploring two Basel Statements.
    Penm J; Chaar B; Dechun J; Moles R
    Am J Health Syst Pharm; 2013 Jun; 70(11):967-79. PubMed ID: 23686603
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Presence of innovation adoption-facilitating elements in hospitals, and relationship to implementation of clinical guidelines.
    Okafor MC; Thomas J
    Ann Pharmacother; 2008 Mar; 42(3):354-60. PubMed ID: 18303144
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drug-use evaluation programs in short-term-care general hospitals.
    Terry AK; Draugalis JR; Bootman JL
    Am J Hosp Pharm; 1993 May; 50(5):940-4. PubMed ID: 8506873
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Drug and Therapeutics Committees in Australia: expected and actual performance.
    Weekes LM; Brooks C
    Br J Clin Pharmacol; 1996 Nov; 42(5):551-7. PubMed ID: 8951185
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical pharmacy services provided in public sector hospitals in Nigeria: a national survey.
    Udoh A; Akpan M; Ibrahim UI; Lawal BK; Labaran KS; Ndem E; Amorha K; Matuluko A; Tikare O; Ohabunwa U; Kpokiri E
    Int J Pharm Pract; 2021 Oct; 29(5):471-479. PubMed ID: 34319400
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inter-role relationships in hospital-based pharmacy and therapeutics committee decision making.
    Bagozzi RP; Ascione FJ; Mannebach MA
    J Health Psychol; 2005 Jan; 10(1):45-64. PubMed ID: 15576500
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of clinical pharmacists in the emergency department of an Australian public hospital: A before and after study.
    Proper JS; Wong A; Plath AE; Grant KA; Just DW; Dulhunty JM
    Emerg Med Australas; 2015 Jun; 27(3):232-8. PubMed ID: 25818918
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Factors influencing the degree of physician-pharmacist collaboration within Iraqi public healthcare settings.
    Al-Jumaili AA; Al-Rekabi MD; Doucette W; Hussein AH; Abbas HK; Hussein FH
    Int J Pharm Pract; 2017 Dec; 25(6):411-417. PubMed ID: 28181318
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A national survey of clinical pharmacy services in county hospitals in China.
    Yao D; Xi X; Huang Y; Hu H; Hu Y; Wang Y; Yao W
    PLoS One; 2017; 12(11):e0188354. PubMed ID: 29190816
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Models of hospital drug policy in the UK.
    Cotter SM; McKee M
    J Health Serv Res Policy; 1997 Jul; 2(3):144-53. PubMed ID: 10180375
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Community/hospital indicators in South African public sector mental health services.
    Lund C; Flisher AJ
    J Ment Health Policy Econ; 2003 Dec; 6(4):181-7. PubMed ID: 14713725
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Improving pharmacy and therapeutics committee operations.
    Cohen MR; Klapp D; Miller KB; Shaffer VL; Slotfeldt M; Miller DE
    Am J Hosp Pharm; 1984 Sep; 41(9):1767-77. PubMed ID: 6496511
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Hospital pharmacists' perception of pharmacovigilance in Quebec].
    Cerruti L; Lebel D; Bussières JF
    Ann Pharm Fr; 2016 Mar; 74(2):137-45. PubMed ID: 26294273
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.